by Nick Paul Taylor |in FierceBiotech on
The European Commission has again sought to extinguish the United Kingdom’s lingering hopes of keeping the European Medicines Agency (EMA) in London after Brexit. Lead Brexiteer David Davis became the latest politician to claim London could retain the regulator earlier this week, only for a spokesperson for the commission to rubbish the idea.
Davis and other members of the British government have generally presented the location of EMA as one of the topics to be decided in its exit negotiations with the EU. Officials in Brussels see things differently. Their take is that the U.K. cannot keep EMA while severing its other ties to the EU, and that the U.K. will have no say in the new location of the agency. That is a decision for the remaining 27 member states. The only role the U.K. has is to ease the transition.
“A matter for the negotiations will be the duty for the United Kingdom to facilitate the transfer of these agencies, helping to ease the practical and financial burden for the experts working there who will have to relocate to another city in the EU,” Margaritis Schinas, a spokesperson for the commission, told BBC News.
…..
Read More / Source: http://www.fiercebiotech.com/biotech/eu-crushes-u-k-hopes-retaining-ema-after-brexit